PantheRx gets CPPA specialty accreditation

WASHINGTON — PantheRx Specialty Pharmacy, a Pennsylvania-based pharmacy with a focus on rare diseases, has received specialty pharmacy practice accreditation from the Center for Pharmacy Practice Accreditation, the organization announced Monday.

“Achieving CPPA accreditation demonstrates PantheRx’s commitment to best in-class clinical programs to support our patients with rare and devastating conditions and their unique needs.” PANTHERx Specialty Pharmacy chairman and CEO Dr. Gordon J. Vanscoy said. “Having a reputable organization like CPPA validates our advanced clinical services and white-glove approach to patient care affirms our mission to redefine the level of care provided in specialty pharmacy.”

CPPA’s focus is on raising the level of patient care delivered by pharmacies through its accreditation, which recognizes practices committed to fostering medication safety and effectiveness, ensuring a consistent approach to delivering outcomes, the organization said.

“Ensuring that specialty pharmacies provide services that help patients achieve desired, cost-effective outcomes is a key component of CPPA’s specialty pharmacy accreditation,” CPPA chairman and America Pharmacists Association EVP and CEO Thomas Menighan said. “CPPA’s accreditation of PantheRx Specialty Pharmacy provides an important recognition that PantheRx pharmacy services support these goals.”